Sp. Bonacorsi et al., ASSESSMENT OF A FLUOROQUINOLONE, 3 BETA-LACTAMS, 2 AMINOGLYCOSIDES, AND A CYCLINE IN TREATMENT OF MURINE YERSINIA-PESTIS INFECTION, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 481-486
Amoxicillin, cefotaxime, ceftriaxone, gentamicin, doxycycline, and ofl
oxacin were active in vitro, like the reference drug streptomycin, aga
inst the virulent strain Yersinia pestis 6/69M. The comparative effica
cies of these drugs in vivo were evaluated in a standardized and repro
ducible mouse model of systemic infection. Each antibiotic was injecte
d intravenously once, at 24 h postinfection, and then repeatedly durin
g 48 h. In vivo results were measured by counting the viable bacteria
recovered from the whole spleens of mice sacrificed at selected times.
All the drugs were manifestly successful; ceftriaxone, ofloxacine, an
d the reference drug were the most effective. Therefore, gentamicin an
d doxycycline could be used, depending on the clinical forms of the Y.
pestis infection. Further investigations on beta-lactams, especially
those used in the present study, could be carried out to confirm or no
t confirm their activities against Y. pestis. Ofloxacin appeared to be
as active and to perform as rapidly as streptomycin in the treatment
of murine Y. pestis infection, which is in agreement with the previous
successes obtained,vith the use of fluoroquinolones in the treatment
of murine infections caused by other pathogenic yersiniae.